Improvement in health status with once-daily indacaterol/glycopyrronium 110/50  μg in COPD patients: real-world evidence from an observational study in Ireland

ConclusionsIn real-life clinical practice in Ireland, IND/GLY 110/50  μg o.d. demonstrated statistically significant and clinically important improvement in health status in patients with COPD.
Source: Irish Journal of Medical Science - Category: General Medicine Source Type: research